Form 4 for KYNB KYNTRA BIO, INC.

Accepted 2023-03-10 00:00:00 ET · period of report 2023-03-08 · accession 0001209191-23-018063 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-03-10	2023-03-08	KYNB	Eisner Mark	Chief Medical Off	A - Grant	$0.00	+20.2K	185.3K	+12%	$0
M	2023-03-10	2023-03-08+	KYNB	Eisner Mark	Chief Medical Off	S - Sale	$20.60	-17.5K	165.1K	-10%	-$360.6K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-03-08	A	A	7,732	$0.00	172,865	D	—	—	(F2) Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023.
2	Common	Common Stock	2023-03-10	S	D	6,255	$20.20	175,176	D	—	—	(F5) Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I.
3	Common	Common Stock	2023-03-08	A	A	12,451	$0.00	185,316	D	—	—	(F3) Represents the number of shares released for PSU TSR Grant vested on March 8, 2023.
4	Common	Common Stock	2023-03-10	S	D	3,885	$20.20	181,431	D	—	—	(F4) Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU Milestone previously reported in Table I.
5	Common	Common Stock	2023-03-08	S	D	7,363	$21.16	165,133	D	—	—	(F1) Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.